Peginterferon Lambda-1a for treatment of outpatients with uncomplicated COVID-19: a randomized placebo-controlled trial
Jagannathan et al., Nature Communications, doi:10.1038/s41467-021-22177-1
https://c19early.org/jagannathan.html